Results 81 to 90 of about 313,394 (308)
Journal of Periodontology, EarlyView.Abstract Background Sodium alendronate (ALN) is widely used to treat postmenopausal osteoporosis, but both estrogen deficiency and antiresorptive therapy may impair alveolar bone repair after tooth extraction. A clinically relevant but insufficiently explored scenario involves estrogen‐deficient individuals receiving hormone replacement therapy (HRT ...
Pedro H. C. Isaias +9 more
wiley +1 more source
Türk Osteoporoz Dergisi, 2023 Objective:Osteoporosis is an important public health problem characterized by the deterioration of the microarchitecture of bone tissue and low bone mineral density.
Erkan Erol, Fatih Okan, Sevil Okan
doaj +1 more source
The effects of royal jelly on human health: A narrative review of clinical studies
JSFA reports, EarlyView.Abstract Royal jelly (RJ) is a natural bioactive substance with documented effects on human health. This narrative review synthesizes evidence from clinical and clinically relevant experimental studies evaluating the therapeutic potential of RJ.
Goras Georgios +2 more
wiley +1 more source
Mapping theme trends and recognizing hot spots in postmenopausal osteoporosis research: a bibliometric analysis [PDF]
PeerJ, 2019 Background This study aimed to draw a series of scientific maps to quantitatively and qualitatively evaluate hot spots and trends in postmenopausal osteoporosis research using bibliometric analysis.
Siming Zhou +3 more
doaj +2 more sources
The Kaohsiung Journal of Medical Sciences, EarlyView.ABSTRACT The prevalence of postmenopausal osteoporosis (PMOP) has been steadily increasing. Ferroptosis has been recognized as a critical factor influencing the bone‐forming ability of bone marrow mesenchymal stem cells (BMSCs). Valproic acid (VPA), an HDAC inhibitor, has been suggested to play a role in regulating osteoporosis development; however ...
Qing‐Song Gu +8 more
wiley +1 more source
European guidance for the diagnosis and management of osteoporosis in postmenopausal women
Osteoporosis International, 2018 SummaryGuidance is provided in a European setting on the assessment and treatment of postmenopausal women at risk from fractures due to osteoporosis.IntroductionThe International Osteoporosis Foundation and European Society for Clinical and Economic ...
J. Kanis +4 more
semanticscholar +1 more source
Determinants of imminent fracture risk in postmenopausal women with osteoporosis
Osteoporosis International, 2020 Summary In elderly women with osteoporosis, prior fracture, low BMD, impaired physical functioning, poorer general health, and recent falls were all direct predictors of imminent (in next year) fracture risk.
Rich Barron +4 more
semanticscholar +1 more source
Mind the Gap: Predictors of Osteoporosis Treatment Following Fragility Fracture in Parkinsonism
Movement Disorders Clinical Practice, EarlyView.Abstract Background Fracture risk is increased in Parkinson's yet this risk is often not addressed. Objectives Our objective was to study the extent to which osteoporosis was treated, and predictors of treatment in a large representative cohort with parkinsonism.
Katie C. Naylor +2 more
wiley +1 more source
Preventive Medicine ReportsObjective: Postmenopausal osteoporosis, affecting 33 % of women over 60 in China, increases fracture risks and significantly impacts quality of life.
Feng Xiong +6 more
doaj +1 more source
HUBUNGAN ANTARA INDEKS MASSA TUBUH (IMT) DAN OSTEOPOROSIS PADA WANITA PASCAMENOPAUSE
Jurnal Profesi Medika, 2015 Has conducted research relationship of body mass index (BMI) and postmenopausal women with osteoporosis in South Sumatra. Method research with a case control study with cae group was post menopausal women with osteoporosis and control group was similar ...
Legiran N, Gita Tanelvi
doaj +1 more source